Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an Anticoagulation Clinic

Italian Heart Journal

Volumn 4, Issue 1, 2003, Pages 44-47

  Poli, Daniela ^a   Antonucci, Emilia ^a   Lombardi, Alessandra ^a   Cecchi, Emanuele ^a   Corsini, Isabella ^a   Gensini, Gian Franco ^a   Abbate, Rosanna ^a   Prisco, Domenico ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anticoagulants; Atrial fibrillation; Bleeding complications

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CONTROLLED STUDY; DIAGNOSTIC KIT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH CENTER; HEART ATRIUM FIBRILLATION; HEMARTHROSIS; HUMAN; INCIDENCE; INTERNATIONAL STANDARD UNIT; INTRAOCULAR HEMORRHAGE; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PROTHROMBIN TIME; RETROPERITONEAL HEMORRHAGE;

ACENOCOUMAROL; ADMINISTRATION, ORAL; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTICOAGULANTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMAN; INCIDENCE; ITALY; MALE; MIDDLE AGE; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME; WARFARIN;

EID: 0037950539     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119 (Suppl): 108S-121S.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-8.
3. Albers GW, Dalen DE, Laupacis A, Manning WJ, Peters P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119 (Suppl): 194S-206S.
4. Italian Federation of Anticoagulation Clinics. A guide to oral anticoagulant therapy. Haemostasis 1998; 28 (Suppl 1): 1-46.
5. Mariani G, Manotti C, Dettori AG. A computerized regulation of dosage in oral anticoagulant therapy. Res Clin Lab 1990; 20: 119-25.
6. Ikuma H, Wada H, Mori Y, et al. Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring. Blood Coagul Fibrinolysis 1999; 10: 429-34.
7. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
8. Palareti G, Leali N, Coccheri S, et al, on behalf of the ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy) Study Group. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-8.
9. Palareti G, Hirsh J, Legnani C, et al. Oral anticoagulation treatment in the elderly. Arch Intern Med 2000; 160: 470-8.
10. Beyth RJ, Landefeld CS. Anticoagulants in older patients: a safety perspective. Drugs Aging 1995; 6: 45-54.
11. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-71.
12. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000; 160: 41-6.
13. Samsa GP, Matchar D, Goldstein L, et al. Quality of anticoagulation management among patients with atrial fibrillation. Arch Intern Med 2000; 160: 967-73.
14. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med 1998; 158: 1641-7.
15. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001; 119 (Suppl): 22S-38S.